Sanofi India Ltd 500674
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 500674 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- INR 8,324.10
- Day Range
- INR 8,388.50–8,499.60
- 52-Week Range
- INR 5,329.70–9,370.35
- Bid/Ask
- INR 8,466.25 / INR 8,486.50
- Market Cap
- INR 194.70 Bil
- Volume/Avg
- 339 / 1,619
Key Statistics
- Price/Earnings (Normalized)
- 32.34
- Price/Sales
- 6.80
- Dividend Yield (Trailing)
- 0.60%
- Dividend Yield (Forward)
- 0.60%
- Total Yield
- 0.60%
Company Profile
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,174
- Website
- https://www.sanofiindialtd.com
Comparables
Valuation
|
Metric
|
500674
|
524348
|
543322
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.34 | 26.34 | 21.59 |
Price/Book Value | 20.25 | 3.84 | 4.36 |
Price/Sales | 6.80 | 1.76 | 4.46 |
Price/Cash Flow | 33.18 | 19.84 | 18.63 |
Price/Earnings
500674
524348
543322
Financial Strength
|
Metric
|
500674
|
524348
|
543322
|
|---|---|---|---|
Quick Ratio | 0.84 | 0.87 | 2.64 |
Current Ratio | 1.92 | 1.61 | 4.37 |
Interest Coverage | 498.35 | 8.39 | 409.34 |
Quick Ratio
500674
524348
543322
Profitability
|
Metric
|
500674
|
524348
|
543322
|
|---|---|---|---|
Return on Assets (Normalized) | 33.84% | — | 16.82% |
Return on Equity (Normalized) | 61.98% | — | 20.87% |
Return on Invested Capital (Normalized) | 54.92% | — | 20.73% |
Return on Assets
500674
524348
543322
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Pqjcwzqmpl | Bggp | $742.4 Bil | |
JNJ
| Johnson & Johnson | Tmfqvkjtz | Ttbr | $363.8 Bil | |
MRK
| Merck & Co Inc | Jmdbcrgv | Vfv | $326.3 Bil | |
ABBV
| AbbVie Inc | Vdtlldlgx | Xxgk | $286.3 Bil | |
AZN
| AstraZeneca PLC ADR | Yhgwfgrsy | Pfb | $235.6 Bil | |
NVS
| Novartis AG ADR | Fqqzfqgl | Fjz | $199.4 Bil | |
RHHBY
| Roche Holding AG ADR | Vhtqmvvdk | Sdlq | $193.6 Bil | |
PFE
| Pfizer Inc | Xpqrggsk | Krnc | $153.9 Bil | |
AMGN
| Amgen Inc | Qxfsxrhxlr | Bcfdk | $148.8 Bil | |
SNY
| Sanofi SA ADR | Hmqrhymm | Sxg | $123.9 Bil |